Abbott Laboratories (NYSE:ABT) recently introduced the FreeStyle Libre 3 Plus in Canada, marking an advancement in diabetes management technology with its small, sensor-based glucose monitoring system ...

Abbott Laboratories’ Debt totaled $15 Bil at the end of the latest quarter, while its market capitalization stands at $233 ...

Abbott Laboratories (NYSE:ABT) is a healthcare company that discovers, develops, manufactures, and sells a range of ...

The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

The biopharmaceutical firm is planning an expansion of its presence in Worcester with the construction of a three-story ...

AbbVie’s history stems from the late 19th-century work of Chicago physician Wallace Calvin Abbott, whose small operation of ...

Abbott Laboratories remains a top pick in volatile markets thanks to strong fundamentals and regulatory tailwinds.

AbbVie remains strong long-term performer, offering a solid dividend yield and robust revenue growth despite share price dips ...

Abbott Laboratories just scored a confidence boost from Oppenheimer after recent CMS policy changes around heart valve repair ...